Aging is not a disease: Distinguishing age-related macular degeneration from aging

Progress in Retinal and Eye Research

Volumn 37, Issue , 2013, Pages 68-89

  Ardeljan, Daniel ^a,b   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Aging; Homeostasis; Oxidative stress; Para inflammation; Retina

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GELATINASE; INTERLEUKIN 10; LIPOFUSCIN; PIGMENT EPITHELIUM DERIVED FACTOR; PYRROLE DERIVATIVE;

AGING; APOPTOSIS; BRUCH MEMBRANE; CELL ACTIVATION; CELL LOSS; CELL POPULATION; CHOROID; CHOROID CAPILLARY LAYER; COMPLEMENT SYSTEM; DRUSEN; EPIGENETICS; GENE EXPRESSION; GEOGRAPHIC ATROPHY; HOMEOSTASIS; HUMAN; MACROGLIA; MACROPHAGE; MICROGLIA; MITOCHONDRION; NERVE CELL PLASTICITY; OXIDATIVE STRESS; PHENOTYPE; PHOTORECEPTOR; PIGMENT EPITHELIUM; POLARIZATION; PRIORITY JOURNAL; PROMOTER REGION; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEUROEPITHELIAL LAYER; REVIEW; SIGNAL TRANSDUCTION; TISSUE DEGENERATION; TURNOVER TIME;

AGE-RELATED MACULAR DEGENERATION; AGING; HOMEOSTASIS; OXIDATIVE STRESS; PARA-INFLAMMATION; RETINA;

AGING; BRUCH MEMBRANE; EYE DISEASES, HEREDITARY; EYE PROTEINS; HUMANS; LIPID METABOLISM; MACULAR DEGENERATION; OXIDATIVE STRESS; RETINAL DRUSEN;

EID: 84887402319     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2013.07.003     Document Type: Review

References (319)

1. Ablonczy Z., Dahrouj M., Tang P.H., Liu Y., Sambamurti K., Marmorstein A.D., Crosson C.E. Human retinal pigment epithelium cells as functional models for the RPE invivo. Invest. Ophthalmol. Vis. Sci. 2011, 52:8614-8620.
2. Ahonen M., Poukkula M., Baker A.H., Kashiwagi M., Nagase H., Eriksson J.E., Kahari V.M. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003, 22:2121-2134.
3. Alsenz J., Schulz T.F., Lambris J.D., Sim R.B., Dierich M.P. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 1985, 232:841-850.
4. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9:1390-1397.
5. Anderson D.H., Radeke M.J., Gallo N.B., Chapin E.A., Johnson P.T., Curletti C.R., Hancox L.S., Hu J., Ebright J.N., Malek G., Hauser M.A., Rickman C.B., Bok D., Hageman G.S., Johnson L.V. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 2010, 29:95-112.
6. Apte R.S., Richter J., Herndon J., Ferguson T.A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 2006, 3.
7. Ardeljan D., Meyerle C.B., Agron E., Jin Wang J., Mitchell P., Chew E.Y., Zhao J., Maminishkis A., Chan C.C., Tuo J. Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration. Eur. J. Hum. Genet. 2013.
8. Ardeljan D., Tuo J., Chan C.C. Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration. Drugs Future 2011, 36:713-718.
9. Ardeljan D., Wang Y., Abu-Asab M., Yu C.R., Tuo J., Shen D., White G., Wadsworth S., Scaria A., Chan C.C. Interleukin-17 Neutralization Ameliorates Retinal Degeneration in Cx3cr1-/-/Ccl2-/-/Crb1rd8 Mice 2013, Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA.
10. AREDS2 Lutein+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013, 309:2005-2015.
11. AREDS Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 2000, 107:2224-2232.
12. AREDS Arandomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 2001, 119:1417-1436.
13. AREDS The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS report no. 7. J.Nutr. 2002, 132:697-702.
14. Baas D.C., Ho L., Ennis S., Merriam J.E., Tanck M.W., Uitterlinden A.G., de Jong P.T., Cree A.J., Griffiths H.L., Rivadeneira F., Hofman A., van Duijn C., Smith R.T., Barile G.R., Gorgels T.G., Vingerling J.R., Klaver C.C., Lotery A.J., Allikmets R., Bergen A.A. The complement component 5 gene and age-related macular degeneration. Ophthalmology 2010, 117:500-511.
15. Ballinger S.W., Van Houten B., Jin G.F., Conklin C.A., Godley B.F. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp. Eye Res. 1999, 68:765-772.
16. Barker F.M., Snodderly D.M., Johnson E.J., Schalch W., Koepcke W., Gerss J., Neuringer M. Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest. Ophthalmol. Vis. Sci. 2011, 52:3934-3942.
17. Barron M.J., Johnson M.A., Andrews R.M., Clarke M.P., Griffiths P.G., Bristow E., He L.P., Durham S., Turnbull D.M. Mitochondrial abnormalities in ageing macular photoreceptors. Invest. Ophthalmol. Vis. Sci. 2001, 42:3016-3022.
18. Baynes J.W. The role of AGEs in aging: causation or correlation. Exp. Gerontol. 2001, 36:1527-1537.
19. Bazan N.G. Neuroprotecting D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005, 15:159-166.
20. Bazan N.G. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J.Lipid Res. 2009, 50(Suppl.):S400-S405.
21. Belayev L., Khoutorova L., Atkins K.D., Bazan N.G. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 2009, 40:3121-3126.
22. Berman D.R., Mozurkewich E., Liu Y., Barks J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am. J. Obstet. Gynecol. 2009, 200:305.e1-305.e6.
23. Berra A., Ferreira S., Stanga P., Llesuy S. Age-related antioxidant capacity of the vitreous and its possible relationship with simultaneous changes in photoreceptors, retinal pigment epithelium and Bruchs' membrane in human donors' eyes. Arch. Gerontol. Geriatr. 2002, 34:371-377.
24. Bhutto I., Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol. Aspects Med. 2012, 33:295-317.
25. Bhutto I.A., Baba T., Merges C., Juriasinghani V., McLeod D.S., Lutty G.A. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br. J. Ophthalmol. 2011, 95:1323-1330.
26. Bhutto I.A., Baba T., Merges C., McLeod D.S., Lutty G.A. Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp. Eye Res. 2010, 90:155-167.
27. Blasiak J., Synowiec E., Salminen A., Kaarniranta K. Genetic variability in DNA repair proteins in age-related macular degeneration. Int. J. Mol. Sci. 2012, 13:13378-13397.
28. Blasiak J., Szaflik J.P. DNA damage and repair in age-related macular degeneration. Front. Biosci. A J. Virtual Lib. 2011, 16:1291-1301.
29. Boltz A., Luksch A., Wimpissinger B., Maar N., Weigert G., Frantal S., Brannath W., Garhofer G., Ergun E., Stur M., Schmetterer L. Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2010, 51:4220-4225.
30. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 2010, 1803:55-71.
31. Bringmann A., Kohen L., Wolf S., Wiedemann P., Reichenbach A. Age-related decrease of potassium currents in glial (Muller) cells of the human retina. Can. J. Ophthalmol. 2003, 38:464-468.
32. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., Osborne N.N., Reichenbach A. Muller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 2006, 25:397-424.
33. Bringmann A., Wiedemann P. Muller glial cells in retinal disease. Ophthalmologica 2012, 227:1-19.
34. Buch H., Nielsen N.V., Vinding T., Jensen G.B., Prause J.U., la Cour M. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 2005, 112:787-798.
35. Butcher M.J., Galkina E.V. Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front. Physiol. 2012, 3:44.
36. Cackett P., Yeo I., Cheung C.M.G., Vithana E.N., Wong D., Tay W.T., Tai E.S., Aung T., Wong T.Y. Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 2011, 118:846-852.
37. Cai H., Del Priore L.V. Bruch membrane aging alters the gene expression profile of human retinal pigment epithelium. Curr. Eye Res. 2006, 31:181-189.
38. Cankova Z., Huang J.D., Kruth H.S., Johnson M. Passage of low-density lipoproteins through Bruch's membrane and choroid. Exp. Eye Res. 2011, 93:947-955.
39. Cao X., Liu M., Tuo J., Shen D., Chan C.C. The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp. Eye Res. 2010, 91:15-25.
40. Cao X., Shen D., Patel M.M., Tuo J., Johnson T.M., Olsen T.W., Chan C.C. Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol. Int. 2011, 61:528-535.
41. Chan-Ling T., Hughes S., Baxter L., Rosinova E., McGregor I., Morcos Y., van Nieuwenhuyzen P., Hu P. Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation 2007, 14:63-76.
42. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
43. Chen H., Liu B., Lukas T.J., Neufeld A.H. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One 2008, 3:e2339.
44. Chen M., Forrester J.V., Xu H. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp. Eye Res. 2007, 84:635-645.
45. Chen M., Forrester J.V., Xu H. Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS One 2011, 6:e22818.
46. Chen M., Muckersie E., Forrester J.V., Xu H. Immune activation in retinal aging: a gene expression study. Invest. Ophthalmol. Vis. Sci. 2010, 51:5888-5896.
47. Chen M., Muckersie E., Robertson M., Forrester J.V., Xu H. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp. Eye Res. 2008, 87:543-550.
48. Chen P.M., Gombart Z.J., Chen J.W. Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci. 2011, 1:10.
49. Chen W., Stambolian D., Edwards A.O., Branham K.E., Othman M., Jakobsdottir J., Tosakulwong N., Pericak-Vance M.A., Campochiaro P.A., Klein M.L., Tan P.L., Conley Y.P., Kanda A., Kopplin L., Li Y., Augustaitis K.J., Karoukis A.J., Scott W.K., Agarwal A., Kovach J.L., Schwartz S.G., Postel E.A., Brooks M., Baratz K.H., Brown W.L., Brucker A.J., Orlin A., Brown G., Ho A., Regillo C., Donoso L., Tian L., Kaderli B., Hadley D., Hagstrom S.A., Peachey N.S., Klein R., Klein B.E., Gotoh N., Yamashiro K., Ferris Iii F., Fagerness J.A., Reynolds R., Farrer L.A., Kim I.K., Miller J.W., Corton M., Carracedo A., Sanchez-Salorio M., Pugh E.W., Doheny K.F., Brion M., Deangelis M.M., Weeks D.E., Zack D.J., Chew E.Y., Heckenlively J.R., Yoshimura N., Iyengar S.K., Francis P.J., Katsanis N., Seddon J.M., Haines J.L., Gorin M.B., Abecasis G.R., Swaroop A. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7401-7406.
50. Chen Y., Bedell M., Zhang K. Age-related macular degeneration: genetic and environmental factors of disease. Mol. Interv. 2010, 10:271-281.
51. Cherepanoff S., McMenamin P., Gillies M.C., Kettle E., Sarks S.H. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br. J. Ophthalmol. 2010, 94:918-925.
52. Chi Z.L., Yoshida T., Lambris J.D., Iwata T. Suppression of drusen formation by compstatin, a peptide inhibitor of complement C3 activation, on cynomolgus monkey with early-onset macular degeneration. Adv. Exp. Med. Biol. 2010, 703:127-135.
53. Chung H.Y., Kim H.J., Kim J.W., Yu B.P. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann. N. Y. Acad. Sci. 2001, 928:327-335.
54. Coleman H.R., Chan C.C., Ferris F.L., Chew E.Y. Age-related macular degeneration. Lancet 2008, 372:1835-1845.
55. Combadiere C., Feumi C., Raoul W., Keller N., Rodero M., Pezard A., Lavalette S., Houssier M., Jonet L., Picard E., Debre P., Sirinyan M., Deterre P., Ferroukhi T., Cohen S.Y., Chauvaud D., Jeanny J.C., Chemtob S., Behar-Cohen F., Sennlaub F. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J.Clin. Invest. 2007, 117:2920-2928.
56. Congdon N., O'Colmain B., Klaver C.C., Klein R., Munoz B., Friedman D.S., Kempen J., Taylor H.R., Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122:477-485.
57. Coscas G., De Benedetto U., Coscas F., Li Calzi C.I., Vismara S., Roudot-Thoraval F., Bandello F., Souied E. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica 2012, 229:32-37.
58. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14682-14687.
59. Curcio C.A., Johnson M., Huang J.D., Rudolf M. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog. Retin. Eye Res. 2009, 28:393-422.
60. Curcio C.A., Johnson M., Huang J.D., Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J.Lipid Res. 2010, 51:451-467.
61. Curcio C.A., Johnson M., Rudolf M., Huang J.-D. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 2011, 95:1638-1645.
62. Curcio C.A., Medeiros N.E., Millican C.L. Photoreceptor loss in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1996, 37:1236-1249.
63. Curcio C.A., Millican C.L., Allen K.A., Kalina R.E. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest. Ophthalmol. Vis. Sci. 1993, 34:3278-3296.
64. Curcio C.A., Millican C.L., Bailey T., Kruth H.S. Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 2001, 42:265-274.
65. Curcio C.A., Presley J.B., Malek G., Medeiros N.E., Avery D.V., Kruth H.S. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 2005, 81:731-741.
66. Damani M.R., Zhao L., Fontainhas A.M., Amaral J., Fariss R.N., Wong W.T. Age-related alterations in the dynamic behavior of microglia. Aging Cell 2011, 10:263-276.
67. Dastgheib K., Green W.R. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch. Ophthalmol. 1994, 112:813-818.
68. DeGroot J., Verzijl N., Wenting-Van Wijk M.J., Bank R.A., Lafeber F.P., Bijlsma J.W., TeKoppele J.M. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum. 2001, 44:2562-2571.
69. Delori F.C., Goger D.G., Dorey C.K. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest. Ophthalmol. Vis. Sci. 2001, 42:1855-1866.
70. Doyle S.L., Campbell M., Ozaki E., Salomon R.G., Mori A., Kenna P.F., Farrar G.J., Kiang A.S., Humphries M.M., Lavelle E.C., O'Neill L.A., Hollyfield J.G., Humphries P. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat. Med. 2012, 18:791-798.
71. Dridi S., Hirano Y., Tarallo V., Kim Y., Fowler B.J., Ambati B.K., Bogdanovich S., Chiodo V.A., Hauswirth W.W., Kugel J.F., Goodrich J.A., Ponicsan S.L., Hinton D.R., Kleinman M.E., Baffi J.Z., Gelfand B.D., Ambati J. ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13781-13786.
72. Ebihara N., Chen L., Tokura T., Ushio H., Iwatsu M., Murakami A. Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells. Ophthalmic Res. 2007, 39:155-163.
73. Ebrahem Q., Renganathan K., Sears J., Vasanji A., Gu X., Lu L., Salomon R.G., Crabb J.W., Anand-Apte B. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13480-13484.
74. Ebrahimi K.B., Handa J.T. Lipids, lipoproteins, and age-related macular degeneration. J.Lipids 2011, 2011:802059.
75. Edwards A.O., Ritter I.R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
76. Eliasieh K., Liets L.C., Chalupa L.M. Cellular reorganization in the human retina during normal aging. Invest. Ophthalmol. Vis. Sci. 2007, 48:2824-2830.
77. Ennis S., Jomary C., Mullins R., Cree A., Chen X., Macleod A., Jones S., Collins A., Stone E., Lotery A. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 2008, 372:1828-1834.
78. Espinosa-Heidmann D.G., Suner I.J., Hernandez E.P., Monroy D., Csaky K.G., Cousins S.W. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2003, 44:3586-3592.
79. Eyerich S., Eyerich K., Cavani A., Schmidt-Weber C. IL-17 and IL-22: siblings, not twins. Trends Immunol. 2010, 31:354-361.
80. Farboud B., Aotaki-Keen A., Miyata T., Hjelmeland L.M., Handa J.T. Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye. Mol. Vis. 1999, 5:11.
81. Fariss R.N., Apte S.S., Olsen B.R., Iwata K., Milam A.H. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am. J. Pathol. 1997, 150:323-328.
82. Feeney L. Lipofuscin and melanin of human retinal pigment epithelium. Fluorescence, enzyme cytochemical, and ultrastructural studies. Invest. Ophthalmol. Vis. Sci. 1978, 17:583-600.
83. Feeney-Burns L., Berman E.R., Rothman H. Lipofuscin of human retinal pigment epithelium. Am. J. Ophthalmol. 1980, 90:783-791.
84. Feher J., Kovacs I., Artico M., Cavallotti C., Papale A., Balacco Gabrieli C. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging 2006, 27:983-993.
85. Ferguson T.A., Apte R.S. Angiogenesis in eye disease: immunity gained or immunity lost?. Semin. Immunopathol. 2008, 30:111-119.
86. Ferreira V.P., Pangburn M.K., Cortes C. Complement control protein factor H: the good, the bad, and the inadequate. Mol. Immunol. 2010, 47:2187-2197.
87. Friedman D.S., O'Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., Kempen J. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122:564-572.
88. Fritsche L.G., Lauer N., Hartmann A., Stippa S., Keilhauer C.N., Oppermann M., Pandey M.K., Kohl J., Zipfel P.F., Weber B.H., Skerka C. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum. Mol. Genet. 2010, 19:4694-4704.
89. Fritsche L.G., Loenhardt T., Janssen A., Fisher S.A., Rivera A., Keilhauer C.N., Weber B.H. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat. Genet. 2008, 40:892-896.
90. Fujihara M., Bartels E., Nielsen L.B., Handa J.T. Ahuman apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp. Eye Res. 2009, 88:1115-1123.
91. Galehdar Z., Swan P., Fuerth B., Callaghan S.M., Park D.S., Cregan S.P. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J.Neurosci. 2010, 30:16938-16948.
92. Gao H., Hollyfield J.G. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1992, 33:1-17.
93. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain research. Brain Res. Rev. 1995, 20:269-287.
94. Gibson J., Hakobyan S., Cree A.J., Collins A., Harris C.L., Ennis S., Morgan B.P., Lotery A.J. Variation in complement component C1 inhibitor in age-related macular degeneration. Immunobiology 2012, 217:251-255.
95. Glenn J.V., Beattie J.R., Barrett L., Frizzell N., Thorpe S.R., Boulton M.E., McGarvey J.J., Stitt A.W. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging. FASEB J. 2007, 21:3542-3552.
96. Glenn J.V., Mahaffy H., Dasari S., Oliver M., Chen M., Boulton M.E., Xu H., Curry W.J., Stitt A.W. Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate. Graefes Arch. Clin. Exp. Ophthalmol. 2012, 250:349-359.
97. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462.
98. Gorgani N.N., He J.Q., Katschke K.J., Helmy K.Y., Xi H., Steffek M., Hass P.E., van Lookeren Campagne M. Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages. J.Immunol. 2008, 181:7902-7908.
99. Goronzy J.J., Weyand C.M. Immune aging and autoimmunity. Cell. Mol. Life Sci. 2012, 69:1615-1623.
100. Green W.R. Histopathology of age-related macular degeneration. Mol. Vis. 1999, 5:27-36.
101. Grossniklaus H.E., Ling J.X., Wallace T.M., Dithmar S., Lawson D.H., Cohen C., Elner V.M., Elner S.G., Sternberg P. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 2002, 8:119-126.
102. Gu J., Pauer G.J., Yue X., Narendra U., Sturgill G.M., Bena J., Gu X., Peachey N.S., Salomon R.G., Hagstrom S.A., Crabb J.W. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol. Cell. Proteomics 2009, 8:1338-1349. the Clinical Genomic and Proteomic AMD Study Group.
103. Gu X., Meer S.G., Miyagi M., Rayborn M.E., Hollyfield J.G., Crabb J.W., Salomon R.G. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J.Biol. Chem. 2003, 278:42027-42035.
104. Gu X., Neric N.J., Crabb J.S., Crabb J.W., Bhattacharya S.K., Rayborn M.E., Hollyfield J.G., Bonilha V.L. Age-related changes in the retinal pigment epithelium (RPE). PLoS One 2012, 7:e38673.
105. Guidry C., Medeiros N.E., Curcio C.A. Phenotypic variation of retinal pigment epithelium in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2002, 43:267-273.
106. Gulcan H.G., Alvarez R.A., Maude M.B., Anderson R.E. Lipids of human retina, retinal pigment epithelium, and Bruch's membrane/choroid: comparison of macular and peripheral regions. Invest. Ophthalmol. Vis. Sci. 1993, 34:3187-3193.
107. Guo L., Hussain A.A., Limb G.A., Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest. Ophthalmol. Vis. Sci. 1999, 40:2676-2682.
108. Guven M., Gorgun E., Unal M., Yenerel M., Batar B., Kucumen B., Dinc U.A., Guven G.S., Ulus T., Yuksel A. Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res. 2011, 46:31-37.
109. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
110. Hammes H.P., Hoerauf H., Alt A., Schleicher E., Clausen J.T., Bretzel R.G., Laqua H. N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1999, 40:1855-1859.
111. Han Y.J., Kwon Y.G., Chung H.T., Lee S.K., Simmons R.L., Billiar T.R., Kim Y.M. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages. Nitric Oxide 2001, 5:504-513.
112. Handa J.T., Verzijl N., Matsunaga H., Aotaki-Keen A., Lutty G.A.,Koppele J.M., Miyata T., Hjelmeland L.M. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest. Ophthalmol. Vis. Sci. 1999, 40:775-779.
113. Hein G., Wiegand R., Lehmann G., Stein G., Franke S. Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology (Oxford) 2003, 42:1242-1246.
114. Helmy K.Y., Katschke K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., Scales S.J., Ghilardi N., van Lookeren Campagne M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 124:915-927.
115. Herrero C., Sebastian C., Marques L., Comalada M., Xaus J., Valledor A.F., Lloberas J., Celada A. Immunosenescence of macrophages: reduced MHC class II gene expression. Exp. Gerontol. 2002, 37:389-394.
116. Hobbs M.V., Weigle W.O., Noonan D.J., Torbett B.E., McEvilly R.J., Koch R.J., Cardenas G.J., Ernst D.N. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J.Immunol. 1993, 150:3602-3614.
117. Hodge W.G., Barnes D., Schachter H.M., Pan Y.I., Lowcock E.C., Zhang L., Sampson M., Morrison A., Tran K., Miguelez M., Lewin G. Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina 2007, 27:216-221.
118. Hodge W.G., Schachter H.M., Barnes D., Pan Y., Lowcock E.C., Zhang L., Sampson M., Morrison A., Tran K., Miguelez M., Lewin G. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 2006, 113:1165-1172.
119. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14:194-198.
120. Hollyfield J.G., Perez V.L., Salomon R.G. Ahapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol. Neurobiol. 2010, 41:290-298.
121. Horie K., Miyata T., Yasuda T., Takeda A., Yasuda Y., Maeda K., Sobue G., Kurokawa K. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem. Biophys. Res. Commun. 1997, 236:327-332.
122. Howes K.A., Liu Y., Dunaief J.L., Milam A., Frederick J.M., Marks A., Baehr W. Receptor for advanced glycation end products and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2004, 45:3713-3720.
123. Hu M., Liu B., Jawad S., Ling D., Casady M., Wei L., Nussenblatt R.B. C5a contributes to intraocular inflammation by affecting retinal pigment epithelial cells and immune cells. Br. J. Ophthalmol. 2011, 95:1738-1744.
124. Huang J.D., Amaral J., Lee J.W., Larrayoz I.M., Rodriguez I.R. Sterculic acid antagonizes 7-ketocholesterol-mediated inflammation and inhibits choroidal neovascularization. Biochim. Biophys. Acta 2012, 1821:637-646.
125. Hughes A.E., Orr N., Esfandiary H., az-Torres M., Goodship T., Chakravarthy U. Acommon CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177.
126. Hunter A., Spechler P.A., Cwanger A., Song Y., Zhang Z., Ying G.S., Hunter A.K., Dezoeten E., Dunaief J.L. DNA methylation is associated with altered gene expression in AMD. Invest. Ophthalmol. Vis. Sci. 2012, 53:2089-2105.
127. Hussain A.A., Lee Y., Marshall J. High molecular-weight gelatinase species of human Bruch's membrane: compositional analyses and age-related changes. Invest. Ophthalmol. Vis. Sci. 2010, 51:2363-2371.
128. Hussain A.A., Lee Y., Zhang J.J., Marshall J. Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52:4459-4466.
129. Hussain A.A., Rowe L., Marshall J. Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. J.Opt. Soc. Am. A Opt. Image Sci. Vis. 2002, 19:166-172.
130. Hussain A.A., Starita C., Hodgetts A., Marshall J. Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD). Exp. Eye Res. 2010, 90:703-710.
131. Isas J.M., Luibl V., Johnson L.V., Kayed R., Wetzel R., Glabe C.G., Langen R., Chen J. Soluble and mature amyloid fibrils in drusen deposits. Invest. Ophthalmol. Vis. Sci. 2010, 51:1304-1310.
132. Jager R.D., Mieler W.F., Miller J.W. Age-related macular degeneration. N.Engl. J. Med. 2008, 358:2606-2617.
133. Jiang B., Bezhadian M.A., Caldwell R.B. Astrocytes modulate retinal vasculogenesis: effects on endothelial cell differentiation. Glia 1995, 15:1-10.
134. Jiang B., Liou G.I., Behzadian M.A., Caldwell R.B. Astrocytes modulate retinal vasculogenesis: effects on fibronectin expression. J.Cell Sci. 1994, 107(Pt 9):2499-2508.
135. Jing G., Wang J.J., Zhang S.X. ER stress and apoptosis: a new mechanism for retinal cell death. Exp. Diabetes Res. 2012, 2012:589589.
136. Johnson L.V., Forest D.L., Banna C.D., Radeke C.M., Maloney M.A., Hu J., Spencer C.N., Walker A.M., Tsie M.S., Bok D., Radeke M.J., Anderson D.H. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18277-18282.
137. Jones M., Mitchell P., Wang J.J., Sue C. MELAS A3243G mitochondrial DNA mutation and age related maculopathy. Am. J. Ophthalmol. 2004, 138:1051-1053.
138. Jono T., Kimura T., Takamatsu J., Nagai R., Miyazaki K., Yuzuriha T., Kitamura T., Horiuchi S. Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain. Pathol. Int. 2002, 52:563-571.
139. Julien S., Schraermeyer U. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol. Aging 2012, 33:2390-2397.
140. Kaarniranta K., Hyttinen J., Ryhanen T., Viiri J., Paimela T., Toropainen E., Sorri I., Salminen A. Mechanisms of protein aggregation in the retinal pigment epithelial cells. Front. Biosci. (Elite Ed.) 2010, 2:1374-1384.
141. Kaarniranta K., Salminen A. NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). Exp. Gerontol. 2009, 44:685-688.
142. Kabasawa S., Mori K., Horie-Inoue K., Gehlbach P.L., Inoue S., Awata T., Katayama S., Yoneya S. Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology 2011, 118:1082-1088.
143. Kamei M., Hollyfield J.G. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1999, 40:2367-2375.
144. Kaneko H., Dridi S., Tarallo V., Gelfand B.D., Fowler B.J., Cho W.G., Kleinman M.E., Ponicsan S.L., Hauswirth W.W., Chiodo V.A., Kariko K., Yoo J.W., Lee D.k., Hadziahmetovic M., Song Y., Misra S., Chaudhuri G., Buaas F.W., Braun R.E., Hinton D.R., Zhang Q., Grossniklaus H.E., Provis J.M., Madigan M.C., Milam A.H., Justice N.L., Albuquerque R.J.C., Blandford A.D., Bogdanovich S., Hirano Y., Witta J., Fuchs E., Littman D.R., Ambati B.K., Rudin C.M., Chong M.M.W., Provost P., Kugel J.F., Goodrich J.A., Dunaief J.L., Baffi J.Z., Ambati J. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011, 471:325-330.
145. Kannan R., Sreekumar P.G., Hinton D.R. VEGF and PEDF secretion in ARPE-19 and fhRPE cells. Invest. Ophthalmol. Vis. Sci. 2011, 52:9047.
146. Karlstetter M., Ebert S., Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology 2010, 215:685-691.
147. Karunadharma P.P., Nordgaard C.L., Olsen T.W., Ferrington D.A. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2010, 51:5470-5479.
148. Kawazoe Y., Sugita S., Keino H., Yamada Y., Imai A., Horie S., Mochizuki M. Retinoic acid from retinal pigment epithelium induces T regulatory cells. Exp. Eye Res. 2012, 94:32-40.
149. Kelly J., Ali K.A., Yin J., Ferguson T.A., Apte R.S. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J.Clin. Invest. 2007, 117:3421-3426.
150. Kenney M.C., Atilano S.R., Boyer D., Chwa M., Chak G., Chinichian S., Coskun P., Wallace D.C., Nesburn A.B., Udar N.S. Characterization of retinal and blood mitochondrial DNA from age-related macular degeneration patients. Invest. Ophthalmol. Vis. Sci. 2010, 51:4289-4297.
151. Kenney M.C., Chwa M., Atilano S.R., Pavlis J.M., Falatoonzadeh P., Ramirez C., Malik D., Hsu T., Woo G., Soe K., Nesburn A.B., Boyer D.S., Kuppermann B.D., Jazwinski S.M., Miceli M.V., Wallace D.C., Udar N. Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One 2013, 8:e54339.
152. Kenney M.C., Hertzog D., Chak G., Atilano S.R., Khatibi N., Soe K., Nobe A., Yang E., Chwa M., Zhu F., Memarzadeh M., King J., Langberg J., Small K., Nesburn A.B., Boyer D.S., Udar N. Mitochondrial DNA haplogroups confer differences in risk for age-related macular degeneration: a case control study. BMC Med. Genet. 2013, 14:4.
153. Kim Y.H., He S., Kase S., Kitamura M., Ryan S.J., Hinton D.R. Regulated secretion of complement factor H by RPE and its role in RPE migration. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:651-659.
154. Kimura T., Takamatsu J., Miyata T., Miyakawa T., Horiuchi S. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains. Pathol. Int. 1998, 48:575-579.
155. Kindt T.J., Goldsby R.A., Osborne B.A., Kuby J. Kuby Immunology 2007, W. H. Freeman, New York. sixth ed.
156. Kinnunen K., Petrovski G., Moe M.C., Berta A., Kaarniranta K. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol. 2012, 90:299-309.
157. Klein R., Meuer S.M., Knudtson M.D., Iyengar S.K., Klein B.E. The epidemiology of retinal reticular drusen. Am. J. Ophthalmol. 2008, 145:317-326.
158. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
159. Knudtson M.D., Klein R., Klein B.E., Lee K.E., Meuer S.M., Tomany S.C. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Invest. Ophthalmol. Vis. Sci. 2004, 45:2135-2142.
160. Korte G.E., Reppucci V., Henkind P. RPE destruction causes choriocapillary atrophy. Invest. Ophthalmol. Vis. Sci. 1984, 25:1135-1145.
161. Krohne T.U., Stratmann N.K., Kopitz J., Holz F.G. Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp. Eye Res. 2010, 90:465-471.
162. Kubo M., Cinader B. Polymorphism of age-related changes in interleukin (IL) production: differential changes of T helper subpopulations, synthesizing IL 2, IL 3 and IL 4. Eur. J. Immunol. 1990, 20:1289-1296.
163. Kumar M.V., Nagineni C.N., Chin M.S., Hooks J.J., Detrick B. Innate immunity in the retina: toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J.Neuroimmunol. 2004, 153:7-15.
164. Lewis G.P., Linberg K.A., Fisher S.K. Neurite outgrowth from bipolar and horizontal cells after experimental retinal detachment. Invest. Ophthalmol. Vis. Sci. 1998, 39:424-434.
165. Li C.M., Chung B.H., Presley J.B., Malek G., Zhang X., Dashti N., Li L., Chen J., Bradley K., Kruth H.S., Curcio C.A. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest. Ophthalmol. Vis. Sci. 2005, 46:2576-2586.
166. Li D.Y., Xue M.Y., Geng Z.R., Chen P.Y. The suppressive effects of Bursopentine (BP5) on oxidative stress and NF-kB activation in lipopolysaccharide-activated murine peritoneal macrophages. Cell. Physiol. Biochem. 2012, 29:9-20.
167. Libby R.T., Gould D.B. Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration. Adv. Exp. Med. Biol. 2010, 664:403-409.
168. Lin H., Xu H., Liang F.Q., Liang H., Gupta P., Havey A.N., Boulton M.E., Godley B.F. Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52:3521-3529.
169. Liu B., Wei L., Meyerle C., Tuo J., Sen H.N., Li Z., Chakrabarty S., Agron E., Chan C.C., Klein M.L., Chew E., Ferris F., Nussenblatt R.B. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J.Transl. Med. 2011, 9:111.
170. Liu L., Ge D., Ma L., Mei J., Liu S., Zhang Q., Ren F., Liao H., Pu Q., Wang T., You Z. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J.Thorac. Oncol. 2012, 7:1091-1100.
171. Lopes K.O., Sparks D.L., Streit W.J. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 2008, 56:1048-1060.
172. Luibl V., Isas J.M., Kayed R., Glabe C.G., Langen R., Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J.Clin. Invest. 2006, 116:378-385.
173. Lutty G., Grunwald J., Majji A.B., Uyama M., Yoneya S. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol. Vis. 1999, 5:35.
174. Ma W., Coon S., Zhao L., Fariss R.N., Wong W.T. A2E accumulation influences retinal microglial activation and complement regulation. Neurobiol. Aging 2013, 34:943-960.
175. Ma W., Lee S.E., Guo J., Qu W., Hudson B.I., Schmidt A.M., Barile G.R. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:1355-1361.
176. Ma W., Zhao L., Fontainhas A.M., Fariss R.N., Wong W.T. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One 2009, 4:e7945.
177. Macgregor A.M., Eberhart C.G., Fraig M., Lu J., Halushka M.K. Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age. J.Histochem. Cytochem. 2009, 57:207-213.
178. Madigan M.C., Penfold P.L., Provis J.M., Balind T.K., Billson F.A. Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age-related macular degeneration. Retina 1994, 14:65-74.
179. Maeda A., Crabb J.W., Palczewski K. Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. Biochemistry 2005, 44:480-489.
180. Mandal M.N., Vasireddy V., Reddy G.B., Wang X., Moroi S.E., Pattnaik B.R., Hughes B.A., Heckenlively J.R., Hitchcock P.F., Jablonski M.M., Ayyagari R. CTRP5 is a membrane-associated and Secretory protein in the RPE and ciliary body and the S163R mutation of CTRP5 Impairs its secretion. Invest. Ophthalmol. Vis. Sci. 2006, 47:5505-5513.
181. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
182. Mantovani A., Garlanda C., Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1419-1423.
183. Mantovani A., Sica A., Locati M. Macrophage polarization comes of age. Immunity 2005, 23:344-346.
184. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
185. Margolis R., Spaide R.F. Apilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am. J. Ophthalmol. 2009, 147:811-815.
186. Mayurasakorn K., Williams J.J., Ten V.S., Deckelbaum R.J. Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14:158-167.
187. McCullough K.D., Martindale J.L., Klotz L.O., Aw T.Y., Holbrook N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 2001, 21:1249-1259.
188. McLeod D.S., Grebe R., Bhutto I., Merges C., Baba T., Lutty G.A. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50:4982-4991.
189. McLeod D.S., Taomoto M., Otsuji T., Green W.R., Sunness J.S., Lutty G.A. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2002, 43:1986-1993.
190. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
191. Miller R.A. Aging and immune function. Int. Rev. Cytol. 1991, 124:187-215.
192. Miyata T., Hori O., Zhang J., Yan S.D., Ferran L., Iida Y., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J.Clin. Invest. 1996, 98:1088-1094.
193. Miyazaki M., Ikeda Y., Yonemitsu Y., Goto Y., Murakami Y., Yoshida N., Tabata T., Hasegawa M., Tobimatsu S., Sueishi K., Ishibashi T. Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models. Hum. Gene Ther. 2011, 22:559-565.
194. Moore D.J., Hussain A.A., Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 1995, 36:1290-1297.
195. Moreira E.F., Larrayoz I.M., Lee J.W., Rodriguez I.R. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Invest. Ophthalmol. Vis. Sci. 2009, 50:523-532.
196. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
197. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
198. Mueller E.E., Schaier E., Brunner S.M., Eder W., Mayr J.A., Egger S.F., Nischler C., Oberkofler H., Reitsamer H.A., Patsch W., Sperl W., Kofler B. Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study. PLoS One 2012, 7:e30874.
199. Mukherjee P., Marcheselli V., de Rivero Vacari J., Gordon W., Jackson F., Bazan N. Photoreceptor outer segment phagocytosis attenuates oxidative-stress induced apoptosis with concomitant neuroprotecting D1 synthesis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13158-13163.
200. Mullins R.F., Faidley E.A., Daggett H.T., Jomary C., Lotery A.J., Stone E.M. Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration. Exp. Eye Res. 2009, 89:767-773.
201. Mullins R.F., Johnson M.N., Faidley E.A., Skeie J.M., Huang J. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52:1606-1612.
202. Mullins R.F., Russell S.R., Anderson D.H., Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000, 14:835-846.
203. Murakami Y., Ikeda Y., Yonemitsu Y., Onimaru M., Nakagawa K., Kohno R., Miyazaki M., Hisatomi T., Nakamura M., Yabe T., Hasegawa M., Ishibashi T., Sueishi K. Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration. Am. J. Pathol. 2008, 173:1326-1338.
204. Nag T.C., Wadhwa S., Alladi P.A., Sanyal T. Localization of 4-hydroxy 2-nonenal immunoreactivity in aging human retinal Muller cells. Ann. Anat. 2011, 193:205-210.
205. Ni J., Yuan X., Gu J., Yue X., Gu X., Nagaraj R.H., Crabb J.W. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration. Mol. Cell. Proteomics 2009, 8:1921-1933.
206. Njemini R., Bautmans I., Lambert M., Demanet C., Mets T. Heat shock proteins and chemokine/cytokine secretion profile in ageing and inflammation. Mech. Ageing Dev. 2007, 128:450-454.
207. Odetti P., Rossi S., Monacelli F., Poggi A., Cirnigliaro M., Federici M., Federici A. Advanced glycation end products and bone loss during aging. Ann. N. Y. Acad. Sci. 2005, 1043:710-717.
208. Parapuram S.K., Cojocaru R.I., Chang J.R., Khanna R., Brooks M., Othman M., Zareparsi S., Khan N.W., Gotoh N., Cogliati T., Swaroop A. Distinct signature of altered homeostasis in aging rod photoreceptors: implications for retinal diseases. PLoS One 2010, 5:e13885.
209. Park K., Jin J., Hu Y., Zhou K., Ma J.X. Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. Am. J. Pathol. 2011, 178:688-698.
210. Park K.H., Ryu E., Tosakulwong N., Wu Y., Edwards A.O. Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects. Mol. Vis. 2009, 15:200-207.
211. Park S., Shen D., Wei L., Wang Y., Eberhart C.G., Nussenblatt R.B., Chan C.C. IL-17A and IL-17RC Expression in the Macula of the Human Eye With Age-related Macular Degeneration 2012, ARVO #1667, Ft. Lauderdale.
212. Pascolini D., Mariotti S.P. Global estimates of visual impairment: 2010. Br. J. Ophthalmol. 2011, 96:614-618.
213. Pascolini D., Mariotti S.P., Pokharel G.P., Pararajasegaram R., Etya'ale D., Negrel A.D., Resnikoff S. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004, 11:67-115.
214. Patel M., Chan C.C. Immunopathological aspects of age-related macular degeneration. Semin. Immunopathol. 2008, 30:97-110.
215. Pauleikhoff D., Harper C.A., Marshall J., Bird A.C. Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology 1990, 97:171-178.
216. Penfold P.L., Killingsworth M.C., Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch. Clin. Exp. Ophthalmol. 1985, 223:69-76.
217. Petrovski G., Berenyi E., Moe M.C., Vajas A., Fesus L., Berta A., Facsko A. Clearance of dying ARPE-19 cells by professional and nonprofessional phagocytes invitro- implications for age-related macular degeneration (AMD). Acta Ophthalmol. 2011, 89:e30-34.
218. Pillin A., Pudil F., Bencko V., Bezdickova D. Contents of pentosidine in the tissue of the intervertebral disc as an indicator of the human age. Soud. Lek. 2007, 52:60-64.
219. Plackett T.P., Schilling E.M., Faunce D.E., Choudhry M.A., Witte P.L., Kovacs E.J. Aging enhances lymphocyte cytokine defects after injury. FASEB J. 2003, 17:688-689.
220. Prasad A.S. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:646-652.
221. Prelog M. Aging of the immune system: a risk factor for autoimmunity?. Autoimmun. Rev. 2006, 5:136-139.
222. Prosser B.E., Johnson S., Roversi P., Herbert A.P., Blaum B.S., Tyrrell J., Jowitt T.A., Clark S.J., Tarelli E., Uhrin D., Barlow P.N., Sim R.B., Day A.J., Lea S.M. Structural basis for complement factor H linked age-related macular degeneration. J.Exp. Med. 2007, 204:2277-2283.
223. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., Anand-Apte B. Anovel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 2003, 9:407-415.
224. Querques G., Querques L., Martinelli D., Massamba N., Coscas G., Soubrane G., Souied E.H. Pathologic insights from integrated imaging of reticular pseudodrusen in age-related macular degeneration. Retina 2011, 31:518-526.
225. Ramirez J.M., Ramirez A.I., Salazar J.J., de Hoz R., Trivino A. Changes of astrocytes in retinal ageing and age-related macular degeneration. Exp. Eye Res. 2001, 73:601-615.
226. Ramrattan R.S., van der Schaft T.L., Mooy C.M., de Bruijn W.C., Mulder P.G., de Jong P.T. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest. Ophthalmol. Vis. Sci. 1994, 35:2857-2864.
227. Reinoso M.A., Mukherjee P., Marcheselli V., Bergsma D., Hesse R., Bazan N. PEDF promotes biosynthesis of a novel anti-inflammatory and anti-apoptotic mediator NPD1 in retinal pigment epithelial cells. Ochsner J. 2008, 8:39-43.
228. Riancho J.A., Zarrabeitia M.T., Amado J.A., Olmos J.M., Gonzalez-Macias J. Age-related differences in cytokine secretion. Gerontology 1994, 40:8-12.
229. Rodriguez I.R., Larrayoz I.M. Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J.Lipid Res. 2010, 51:2847-2862.
230. Rohrer B., Coughlin B., Bandyopadhyay M., Holers V.M. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J.Ocul. Pharmacol. Ther. 2012, 28:402-409.
231. Rohrer B., Long Q., Coughlin B., Renner B., Huang Y., Kunchithapautham K., Ferreira V.P., Pangburn M.K., Gilkeson G.S., Thurman J.M., Tomlinson S., Holers V.M. Atargeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv. Exp. Med. Biol. 2010, 703:137-149.
232. Roque R.S., Rosales A.A., Jingjing L., Agarwal N., Al-Ubaidi M.R. Retina-derived microglial cells induce photoreceptor cell death invitro. Brain Res. 1999, 836:110-119.
233. Rosenbaum J.T. Eyeing macular degeneration - few inflammatory remarks. N.Engl. J. Med. 2012, 367:768-770.
234. Rudolf M., Clark M.E., Chimento M.F., Li C.M., Medeiros N.E., Curcio C.A. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 2008, 49:1200-1209.
235. Rudolf M., Vogt S.D., Curcio C.A., Huisingh C., McGwin G., Wagner A., Grisanti S., Read R.W. Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy. Ophthalmology 2013, 120:821-828.
236. Rudolf M., Winkler B., Aherrahou Z., Doehring L.C., Kaczmarek P., Schmidt-Erfurth U. Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br. J. Ophthalmol. 2005, 89:1627-1630.
237. Rutar M.V., Natoli R.C., Provis J.M. Small interfering RNA-mediated suppression of Ccl2 in Muller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration. J.Neuroinflammation 2012, 9:221.
238. Salminen A., Kauppinen A., Hyttinen J.M., Toropainen E., Kaarniranta K. Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization. Mol. Med. 2010, 16:535-542.
239. Sanchez A., Tripathy D., Yin X., Luo J., Martinez J., Grammas P. Pigment epithelium-derived factor (PEDF) protects cortical neurons invitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1/2 and induction of Bcl-2. Neurosci. Res. 2012, 72:1-8.
240. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976, 60:324-341.
241. Sauer T., Patel M., Chan C.C., Tuo J. Unfolding the therapeutic potential of chemical chaperones for age-related macular degeneration. Expert Rev. Ophthalmol. 2008, 3:29-42.
242. Schmidt A.M., Hasu M., Popov D., Zhang J.H., Chen J., Yan S.D., Brett J., Cao R., Kuwabara K., Costache G., et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8807-8811.
243. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.D., Brett J., Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J.Clin. Invest. 1995, 96:1395-1403.
244. Schmitz-Valckenberg S., Steinberg J.S., Fleckenstein M., Visvalingam S., Brinkmann C.K., Holz F.G. Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 2010, 117:1169-1176.
245. Scholl H.P., Charbel Issa P., Walier M., Janzer S., Pollok-Kopp B., Borncke F., Fritsche L.G., Chong N.V., Fimmers R., Wienker T., Holz F.G., Weber B.H., Oppermann M. Systemic complement activation in age-related macular degeneration. PLoS One 2008, 3:e2593.
246. Schutt F., Aretz S., Auffarth G.U., Kopitz J. Moderately reduced ATP levels promote oxidative stress and debilitate autophagic and phagocytic capacities in human RPE cells. Invest. Ophthalmol. Vis. Sci. 2012, 53:5354-5361.
247. Seddon J.M., Cote J., Davis N., Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio 34. Arch. Ophthalmol. 2003, 121:785-792.
248. Seddon J.M., Cote J., Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol. 2003, 121:1728-1737.
249. Seddon J.M., George S., Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US twin study of age-related macular degeneration. Arch. Ophthalmol. 2006, 124:995-1001.
250. Seddon J.M., Reynolds R., Shah H.R., Rosner B. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology 2011, 118:1386-1394.
251. Seddon J.M., Willett W.C., Speizer F.E., Hankinson S.E. Aprospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996, 276:1141-1146.
252. Sheikpranbabu S., Haribalaganesh R., Gurunathan S. Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes. Diabetes Metab. 2011, 37:505-511.
253. Shelley E.J., Madigan M.C., Natoli R., Penfold P.L., Provis J.M. Cone degeneration in aging and age-related macular degeneration. Arch. Ophthalmol. 2009, 127:483-492.
254. Shen D., Cao X., Zhao L., Tuo J., Wong W.T., Chan C.C. Naloxone ameliorates retinal lesions in Ccl2/Cx3cr1 double-deficient mice via modulation of microglia. Invest. Ophthalmol. Vis. Sci. 2011, 52:2897-2904.
255. Sheng J.G., Mrak R.E., Griffin W.S. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol. 1998, 95:229-234.
256. Sieving P.A., Caruso R.C., Tao W., Coleman H.R., Thompson D.J., Fullmer K.R., Bush R.A. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3896-3901.
257. Skeie J.M., Mullins R.F. Macrophages in neovascular age-related macular degeneration: friends or foes?. Eye (Lond) 2009, 23:747-755.
258. Spaide R.F., Curcio C.A. Drusen characterization with multimodal imaging. Retina 2010, 30:1441-1454.
259. Spaide R.F., Ho-Spaide W.C., Browne R.W., Armstrong D. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999, 19:141-147.
260. Sparrow J.R. Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Adv. Exp. Med. Biol. 2010, 703:63-74.
261. Sparrow J.R., Gregory-Roberts E., Yamamoto K., Blonska A., Ghosh S.K., Ueda K., Zhou J. The bisretinoids of retinal pigment epithelium. Prog. Retin. Eye Res. 2012, 31:121-135.
262. Sparrow J.R., Nakanishi K., Parish C.A. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 2000, 41:1981-1989.
263. Spencer K.L., Hauser M.A., Olson L.M., Schmidt S., Scott W.K., Gallins P., Agarwal A., Postel E.A., Pericak-Vance M.A., Haines J.L. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum. Mol. Genet. 2007, 16:1986-1992.
264. Spraul C.W., Lang G.E., Grossniklaus H.E. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1996, 37:2724-2735.
265. Spraul C.W., Lang G.E., Grossniklaus H.E., Lang G.K. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv. Ophthalmol. 1999, 44(Suppl.1):S10-S32.
266. Starita C., Hussain A.A., Marshall J. Decreasing hydraulic conductivity of Bruch's membrane: relevance to photoreceptor survival and lipofuscinoses. Am. J. Med. Genet. 1995, 57:235-237.
267. Starita C., Hussain A.A., Pagliarini S., Marshall J. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp. Eye Res. 1996, 62:565-572.
268. Starita C., Hussain A.A., Patmore A., Marshall J. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 1997, 38:762-767.
269. Streit W.J., Sammons N.W., Kuhns A.J., Sparks D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45:208-212.
270. Sue C.M., Mitchell P., Crimmins D.S., Moshegov C., Byrne E., Morris J.G. Pigmentary retinopathy associated with the mitochondrial DNA 3243 point mutation. Neurology 1997, 49:1013-1017.
271. Sugita S., Horie S., Yamada Y., Mochizuki M. Inhibition of B-cell activation by retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2010, 51:5783-5788.
272. Sullivan R., Penfold P., Pow D.V. Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD. Invest. Ophthalmol. Vis. Sci. 2003, 44:856-865.
273. Sullivan R.K., Woldemussie E., Pow D.V. Dendritic and synaptic plasticity of neurons in the human age-related macular degeneration retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:2782-2791.
274. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 2010, 10:36-46.
275. Tarallo V., Hirano Y., Gelfand B.D., Dridi S., Kerur N., Kim Y., Cho W.G., Kaneko H., Fowler B.J., Bogdanovich S., Albuquerque R.J., Hauswirth W.W., Chiodo V.A., Kugel J.F., Goodrich J.A., Ponicsan S.L., Chaudhuri G., Murphy M.P., Dunaief J.L., Ambati B.K., Ogura Y., Yoo J.W., Lee D.K., Provost P., Hinton D.R., Nunez G., Baffi J.Z., Kleinman M.E., Ambati J. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012, 149:847-859.
276. Terzibasi E., Calamusa M., Novelli E., Domenici L., Strettoi E., Cellerino A. Age-dependent remodelling of retinal circuitry. Neurobiol. Aging 2009, 30:819-828.
277. Thampi P., Rao H.V., Mitter S.K., Cai J., Mao H., Li H., Seo S., Qi X., Lewin A.S., Romano C., Boulton M.E. The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium. PLoS One 2012, 7:e34468.
278. Totan Y., Yagci R., Bardak Y., Ozyurt H., Kendir F., Yilmaz G., Sahin S., Sahin Tig U. Oxidative macromolecular damage in age-related macular degeneration. Curr. Eye Res. 2009, 34:1089-1093.
279. Tuo J., Ardeljan D., Meyerle C.B., Wang J.J., Mitchell P., Chew E.Y., Chan C.C. Influence of TIMP3/SYN1 Variation on the Phenotypic Presentation of Age-related Macular Degeneration 2012, ARVO Abstract #3314, Ft. Lauderdale, FL.
280. Tuo J., Ross R.J., Herzlich A.A., Shen D., Ding X., Zhou M., Coon S.L., Hussein N., Salem N., Chan C.C. Ahigh omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am. J. Pathol. 2009, 175:799-807.
281. Ugarte M., Hussain A.A., Marshall J. An experimental study of the elastic properties of the human Bruch's membrane-choroid complex: relevance to ageing. Br. J. Ophthalmol. 2006, 90:621-626.
282. Unterlauft J.D., Eichler W., Kuhne K., Yang X.M., Yafai Y., Wiedemann P., Reichenbach A., Claudepierre T. Pigment epithelium-derived factor released by Muller glial cells exerts neuroprotective effects on retinal ganglion cells. Neurochem. Res. 2012, 37:1524-1533.
283. van Deemter M., Ponsioen T.L., Bank R.A., Snabel J.M., van der Worp R.J., Hooymans J.M., Los L.I. Pentosidine accumulates in the aging vitreous body: a gender effect. Exp. Eye Res. 2009, 88:1043-1050.
284. Venza I., Visalli M., Cucinotta M., Teti D., Venza M. Association between oxidative stress and macromolecular damage in elderly patients with age-related macular degeneration. Aging Clin. Exp. Res. 2012, 24:21-27.
285. Wang A.L., Lukas T.J., Yuan M., Du N., Tso M.O., Neufeld A.H. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One 2009, 4:e4160.
286. Wang A.L., Lukas T.J., Yuan M., Neufeld A.H. Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol. Vis. 2008, 14:644-651.
287. Wang G., Spencer K.L., Court B.L., Olson L.M., Scott W.K., Haines J.L., Pericak-Vance M.A. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest. Ophthalmol. Vis. Sci. 2009, 50:3084-3090.
288. Wang J.J., Foran S., Smith W., Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch. Ophthalmol. 2003, 121:658-663.
289. Wang L., Clark M.E., Crossman D.K., Kojima K., Messinger J.D., Mobley J.A., Curcio C.A. Abundant lipid and protein components of drusen. PLoS One 2010, 5:e10329.
290. Wang X.F., Cui J.Z., Nie W., Prasad S.S., Matsubara J.A. Differential gene expression of early and late passage retinal pigment epithelial cells. Exp. Eye Res. 2004, 79:209-221.
291. Wang Y., Bian Z.M., Yu W.Z., Yan Z., Chen W.C., Li X.X. Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells. Exp. Eye Res. 2010, 91:135-142.
292. Wang Y., Shen D., Wang V.M., Yu C.R., Wang R.X., Tuo J., Chan C.C. Enhanced apoptosis in retinal pigment epithelium under inflammatory stimuli and oxidative stress. Apoptosis 2012, 17:1144-1155.
293. Ward R.E., Huang W., Curran O.E., Priestley J.V., Michael-Titus A.T. Docosahexaenoic acid prevents white matter damage after spinal cord injury. J.Neurotrauma 2010, 27:1769-1780.
294. Wasmuth S., Lueck K., Baehler H., Lommatzsch A., Pauleikhoff D. Increased vitronectin production by complement-stimulated human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2009, 50:5304-5309.
295. Wei L., Liu B., Tuo J., Shen D., Chen P., Li Z., Liu X., Ni J., Dagur P., Sen H.N., Jawad S., Ling D., Park S., Chakrabarty S., Meyerle C., Agron E., Ferris F.L., Chew E.Y., McCoy J.P., Blum E., Francis P.J., Klein M.L., Guymer R.H., Baird P.N., Chan C.C., Nussenblatt R.B. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep. 2012, 2:1151-1158.
296. West X.Z., Malinin N.L., Merkulova A.A., Tischenko M., Kerr B.A., Borden E.C., Podrez E.A., Salomon R.G., Byzova T.V. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010, 467:972-976.
297. Wood A., Binns A., Margrain T., Drexler W., Povazay B., Esmaeelpour M., Sheen N. Retinal and choroidal thickness in early age-related macular degeneration. Am. J. Ophthalmol. 2011, 152. 1030-1038.e2.
298. Wu K.H., Madigan M.C., Billson F.A., Penfold P.L. Differential expression of GFAP in early v late AMD: a quantitative analysis. Br. J. Ophthalmol. 2003, 87:1159-1166.
299. Wu W.K., Llewellyn O.P., Bates D.O., Nicholson L.B., Dick A.D. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology 2010, 215:796-803.
300. Wu Y., Zhou J., Fishkin N., Rittmann B.E., Sparrow J.R. Enzymatic degradation of A2E, a retinal pigment epithelial lipofuscin bisretinoid. J.Am. Chem. Soc. 2011, 133:849-857.
301. Xu H., Chen M., Forrester J.V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 2009, 28:348-368.
302. Xu H., Chen M., Manivannan A., Lois N., Forrester J.V. Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008, 7:58-68.
303. Xu H., Chen M., Mayer E.J., Forrester J.V., Dick A.D. Turnover of resident retinal microglia in the normal adult mouse. Glia 2007, 55:1189-1198.
304. Xu W., Grunwald J.E., Metelitsina T.I., DuPont J.C., Ying G.S., Martin E.R., Dunaief J.L., Brucker A.J. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am. J. Ophthalmol. 2010, 150. 40-47.e2.
305. Yamada Y., Ishibashi K., Ishibashi K., Bhutto I.A., Tian J., Lutty G.A., Handa J.T. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas. Exp. Eye Res. 2006, 82:840-848.
306. Yan S.D., Roher A., Schmidt A.M., Stern D.M. Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to invivo. Am. J. Pathol. 1999, 155:1403-1411.
307. Yates J.R., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., Armbrecht A.M., Dhillon B., Deary I.J., Redmond E., Bird A.C., Moore A.T. Complement C3 variant and the risk of age-related macular degeneration. N.Engl. J. Med. 2007, 357:553-561.
308. Ye S.M., Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J.Neuroimmunol. 1999, 93:139-148.
309. Yin L., Shi Y., Liu X., Zhang H., Gong Y., Gu Q., Wu X., Xu X. Arat model for studying the biological effects of circulating LDL in the choriocapillaris-BrM-RPE complex. Am. J. Pathol. 2012, 180:541-549.
310. Yoon K.D., Yamamoto K., Ueda K., Zhou J., Sparrow J.R. Anovel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration. PLoS One 2012, 7:e41309.
311. Yu Y., Bhangale T.R., Fagerness J., Ripke S., Thorleifsson G., Tan P.L., Souied E.H., Richardson A.J., Merriam J.E., Buitendijk G.H., Reynolds R., Raychaudhuri S., Chin K.A., Sobrin L., Evangelou E., Lee P.H., Lee A.Y., Leveziel N., Zack D.J., Campochiaro B., Campochiaro P., Smith R.T., Barile G.R., Guymer R.H., Hogg R., Chakravarthy U., Robman L.D., Gustafsson O., Sigurdsson H., Ortmann W., Behrens T.W., Stefansson K., Uitterlinden A.G., van Duijn C.M., Vingerling J.R., Klaver C.C., Allikmets R., Brantley M.A., Baird P.N., Katsanis N., Thorsteinsdottir U., Ioannidis J.P., Daly M.J., Graham R.R., Seddon J.M. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum. Mol. Genet. 2011, 20:3699-3709.
312. Zamiri P., Sugita S., Streilein J.W. Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem. Immunol. Allergy 2007, 92:86-93.
313. Zealley B., de Grey A.D. Strategies for engineered negligible senescence. Gerontology 2013, 59:183-189.
314. Zhang K., Hopkins J.J., Heier J.S., Birch D.G., Halperin L.S., Albini T.A., Brown D.M., Jaffe G.J., Tao W., Williams G.A. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6241-6245.
315. Zhao L., Ma W., Fariss R.N., Wong W.T. Minocycline attenuates photoreceptor degeneration in a mouse model of subretinal hemorrhage microglial: inhibition as a potential therapeutic strategy. Am. J. Pathol. 2011, 179:1265-1277.
316. Zhou J., Jang Y.P., Kim S.R., Sparrow J.R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16182-16187.
317. Zhou J., Kim S.R., Westlund B.S., Sparrow J.R. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest. Ophthalmol. Vis. Sci. 2009, 50:1392-1399.
318. Zweifel S.A., Imamura Y., Spaide T.C., Fujiwara T., Spaide R.F. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010, 117:1775-1781.
319. Zweifel S.A., Spaide R.F., Curcio C.A., Malek G., Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010, 117. 303-312.e1.